Stock Events

Stock Events

Vistin Pharma ASA 

SEK21.4
0
+SEK0+0% Wednesday 08:00

Statistics

Day High
-
Day Low
-
52W High
25.6
52W Low
19.75
Volume
-
Avg. Volume
262
Mkt Cap
948.98M
P/E Ratio
-
Dividend Yield
4.51%
Dividend
0.97

Upcoming

25
MAY
Dividend Ex
Decreased
 
29
MAY
Dividend Payment
Decreased
 
25
MAY 27
Dividend Ex
Estimated
 
28
MAY 27
Dividend Payment
Estimated
 

Dividends

4.51%Dividend Yield
Jun 25
SEK1.19
Nov 24
SEK0.49
Jun 24
SEK0.49
Jan 24
SEK0.75
Jun 21
SEK0.5
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-19.88%

Financials

16.71%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.15BRevenue
192.35MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VISTINO.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Vistin Pharma's focus on pharmaceuticals and medical solutions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global biopharmaceutical company that produces medicines and vaccines for a wide range of medical disciplines, including areas where Vistin Pharma operates.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. provides healthcare solutions that include pharmaceutical, vaccines, biologic therapies, and animal health products, competing in the pharmaceuticals sector with Vistin Pharma.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of products in various therapeutic areas, competing with Vistin Pharma in the pharmaceutical market.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that researches, develops, and manufactures innovative pharmaceutical medicines, vaccines, and consumer healthcare products, competing with Vistin Pharma.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a multinational corporation that produces pharmaceuticals, medical devices, and consumer packaged goods, directly competing with Vistin Pharma in the healthcare sector.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focused on human health, offering a broad range of medicines and vaccines, which puts it in competition with Vistin Pharma.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Vistin Pharma in the pharmaceutical and healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, competing with Vistin Pharma.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Vistin Pharma in various therapeutic areas.

About

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Show more...
CEO
ISIN
NO0010734122

Listings

ST
SE
VISTINO.ST
LSE
GB
0RAM.LSE
OL
NO
VISTN.OL
F
DE
VP4.F

0 Comments

Share your thoughts

FAQ

What is Vistin Pharma ASA stock price today?▼
The current price of VISTINO.ST is SEK21.4 SEK — it has increased by +0% in the past 24 hours. Watch Vistin Pharma ASA stock price performance more closely on the chart.
What is Vistin Pharma ASA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vistin Pharma ASA stocks are traded under the ticker VISTINO.ST.
What is Vistin Pharma ASA market cap?▼
Today Vistin Pharma ASA has the market capitalization of 948.98M
What is Vistin Pharma ASA revenue for the last year?▼
Vistin Pharma ASA revenue for the last year amounts to 1.15B SEK.
What is Vistin Pharma ASA net income for the last year?▼
VISTINO.ST net income for the last year is 192.35M SEK.
Does Vistin Pharma ASA pay dividends?▼
Yes, VISTINO.ST dividends are paid semi-annual. The last dividend per share was 1.19 SEK. As of today, Dividend Yield (FWD)% is 4.51%.
When did Vistin Pharma ASA complete a stock split?▼
Vistin Pharma ASA has not had any recent stock splits.